Detalhe da pesquisa
1.
Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 Years.
Respiration
; 102(1): 25-33, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366821
2.
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State.
Viruses
; 15(10)2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37896877
3.
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study.
Diagnostics (Basel)
; 13(11)2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296734
4.
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies.
Diagnostics (Basel)
; 12(5)2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626295
5.
Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib.
Arch Bronconeumol
; 59(7): 464-466, 2023 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36894471